All Viruses articles – Page 7
-
NewsResearch reveals fetuses exposed to Zika virus have long-term immune challenges
Researchers discovered that when a pregnant mother is infected with Zika virus, the resulting inflammatory response in the placenta permanently changes how the offspring’s immune system develops - even if the infection is mild or asymptomatic in the mother.
-
NewsLong Ebola: Sudan virus can persist in survivors for months, study shows
More than half of survivors of the Sudan Ebola virus still suffer serious health problems two years post-infection and the virus can persist in semen and breast milk for months after recovery, according to the first study examining the virus’s long-term effects.
-
NewsSpotlight on phage for a fascinating policy discussion
Scientists turned the spotlight onto the potential of phage in a recent AMI webinar that yielded a fascinating in-depth discussion that proved invaluable in clarifying the way forward. The ‘Phages for a Sustainable Future’ webinar has now been released as a video.
-
NewsScientists explore how viruses replicate and infect
Herpes viruses cultivated using one kind of host cell – known as a producer cell – exhibited differences from the same virus cultivated with a different producer cell.
-
NewsViruses help cut farm greenhouse gas emissions by targeting soil microbes
A new study reveals that soil viruses can reduce nitrous oxide (N2O) emissions by selectively infecting the microbes responsible for producing this potent greenhouse gas.
-
NewsResearchers deconstruct chikungunya outbreaks to improve prediction and vaccine development
Researchers analyzed more than 80 outbreaks of chikungunya virus to improve prediction of future outbreaks and inform vaccine trial development.
-
NewsThe RESTART trial: a drug to block a toxic HIV molecule
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment? Researchers will explore this in a groundbreaking clinical trial this fall.
-
NewsAI can be valuable tool to strengthen pandemic preparedness
Artificial intelligence could be a valuable tool for detecting emerging diseases earlier, researchers from five European universities and research institutes argue.
-
NewsSome human GII.4 norovirus are better than others at infecting cells; researchers have found out why
A study reveals that human GII.4 noroviruses have evolved a uniquely potent entry mechanism with clear strain-specific differences. The findings open new possibilities for identifying the elusive human norovirus receptor as well as developing vaccines and treatments.
-
NewsHeart rhythm disorder POTS common in patients with long COVID
A new study shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those affected are middle-aged women.
-
NewsBreakthrough results from elephant herpesvirus trial find vaccine to be safe
The world’s first vaccine trial against elephant endotheliotropic herpesvirus (EEHV) – a leading cause of death in young Asian elephants – is safe and triggers a strong virus-fighting immune response, according to a research team.
-
NewsScientists develop rapid and scalable platform for in planta directed evolution
Researchers have developed a new system that enables rapid and scalable directed evolution of diverse genes directly in plant cells. To address the challenge of slow cell division rate in plants, the researchers harnessed geminiviruses.
-
NewsGenetic ‘Trojan horse’ selectively kills cancer cells linked to Kaposi’s sarcoma
A highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus harnesses an adeno-associated virus (AAV) to deliver a genetic “Trojan horse” into infected cells.
-
NewsNew herpes virus–based vaccine could cure cancer in the future without side effects
The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes virus can be repurposed as a cancer vaccine.
-
NewsIndia could bear biggest impact from chikungunya, new maps suggest
Based on existing evidence of chikungunya transmission, an infectious disease model predicts 14.4 million people could be at risk of infections globally each year, with 5.1 million people at risk in India.
-
NewsA step toward diagnosing the flu with your tongue
A new molecular sensor has been designed to release a thyme flavor when it encounters the influenza virus. Researchers plan to incorporate this type of low-tech sensor into gum or lozenges to increase at-home screenings and potentially prevent pre-symptomatic transmission of the disease.
-
NewsScientist awarded $5 million to improve mental health and HIV care for adolescents in Uganda
The National Institutes of Health (NIH) has awarded Dr. Philip Kreniske $5,115,391 for a groundbreaking research project to improve mental health and antiretroviral treatment adherence among adolescents living with HIV in rural Uganda.
-
NewsBrain imaging technique helps uncover the molecular basis of long COVID brain fog
A research team has made a significant breakthrough in understanding the cause of Long COVID brain fog. They hypothesized that patients with brain fog might exhibit disrupted expression of AMPA receptors (AMPARs)based on prior research into psychiatric and neurological disorders.
-
NewsEmerging serum biomarkers for chronic hepatitis B: Focus on serum HBV RNA and HBcrAg
There is a pressing need for non-invasive biomarkers that can accurately reflect the activity of the hepatitis B viral reservoir and predict clinical outcomes. This review synthesizes the evidence for two such promising biomarkers: serum HBV RNA and hepatitis B core-related antigen (HBcrAg).
-
NewsResearchers uncover HIV mystery that could unlock the path to a cure
Researchers have identified for the first time how HIV enters a dormant state in infected cells that allows the virus to “hide” from the immune system and current treatments. HIV orchestrates its own survival by reprogramming host cells to create the perfect hiding place.